Fundz

Biostate AI raised over $4 million in venture funding led by Matter Venture Partners

PRIVATEJul 12, 2024

Amount Raised

$4 Million

Round Type

Funding Round

Palo AltoOtherBiotechnology

Investors

Emily Leproust (Ceo Of Twist Bioscience)Michael Schnall Levin (Cto Of 10 X Genomics)Joris Poort (Ceo Of Rescale)Dario Amodei (Ceo Of Anthropic)California Institute Of TechnologyCatapult VCVision Plus CapitalMatter Venture Partners

Description

Biostate AI, a scalable biodata foundry startup, has emerged from stealth with the launch of two service products and recently revealed it has raised over $4 million in venture funding. Matter Venture Partners led the funding round, with participation from institutional investors Vision Plus Capital, Catapult VC, and the California Institute of Technology through the Caltech Seed Fund, as well as individual investors.

Quick answer

Biostate AI raised $4 Million in a Funding Round round, dated July 12, 2024. Investors: Emily Leproust (Ceo Of Twist Bioscience), Michael Schnall Levin (Cto Of 10 X Genomics), Joris Poort (Ceo Of Rescale), Dario Amodei (Ceo Of Anthropic), California Institute Of Technology, Catapult VC, Vision Plus Capital and Matter Venture Partners. Biostate AI is based in Palo Alto, California, United States.

How much did Biostate AI raise?
Biostate AI raised $4 Million in a Funding Round round on July 12, 2024.
Who invested in Biostate AI?
Emily Leproust (Ceo Of Twist Bioscience), Michael Schnall Levin (Cto Of 10 X Genomics), Joris Poort (Ceo Of Rescale), Dario Amodei (Ceo Of Anthropic), California Institute Of Technology, Catapult VC, Vision Plus Capital and Matter Venture Partners are named as investors in this round.
What does Biostate AI do?
Biostate AI is a startup building generative AI that predicts the evolution of human disease and drug response based on RNA sequencing data.
Where is Biostate AI based and how big is it?
Biostate AI is based in Palo Alto, California, United States.
Who are the decision-makers at Biostate AI?
Fundz holds 1 contact at Biostate AI. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Biostate AI that raised within 45 days of this round, from Fundz verified event records.

  • CuraSen Therapeutics raised $5.8M on August 26, 2024.
  • Zyppah raised $60K (Pre-Seed) on August 26, 2024.
  • Diakonos Oncology raised $11M (Seed) on August 26, 2024.
  • Oncotect raised $125K (Pre-Seed) on August 26, 2024.
  • XO Life raised $7.8M on August 23, 2024.
  • Navigator Medicines raised $50M on August 23, 2024.

Who to call at Biostate AI, and when

A new round usually means Biostate AI is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Biostate AI raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Biostate AI, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Biostate AI. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Biostate AI

Location

Palo Alto, California, United States

About

Biostate AI is a startup building generative AI that predicts the evolution of human disease and drug response based on RNA sequencing data. Its patented wetlab technologies, including BIRT, allow affordable and scalable collection of massive amounts of transcriptomic and genomic data. With sites in Houston, TX, Palo Alto, CA, Bangalore, India, and Shanghai, China, Biostate AI is a global company with collaborations with top hospitals, academic researchers, and biotech/biopharma companies. Biostate AI was founded by serial entrepreneurs and former professors David Zhang (Rice U.) and Ashwin Gopinath (MIT) and is backed by top investors and experts including Accel, Dario Amodei (Anthropic), Emily Leproust (Twist Biosciences), and Mike Schnall-Levin (10X Genomics).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Biostate AI raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Biostate AI's next move

See what Strategic adds

Biostate AI raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.